Grant Skrepnek to Health Care Costs
This is a "connection" page, showing publications Grant Skrepnek has written about Health Care Costs.
Connection Strength
1.364
-
A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010. PLoS One. 2015; 10(8):e0134914.
Score: 0.478
-
Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012 Apr; 9(2):131-41.
Score: 0.377
-
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Curr Med Res Opin. 2005 Feb; 21(2):261-70.
Score: 0.230
-
Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001-2010. Leuk Lymphoma. 2014 Apr; 55(4):834-40.
Score: 0.104
-
Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S41-53.
Score: 0.100
-
Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005 Mar; 25(3):325-34.
Score: 0.058
-
Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System. Pharmacotherapy. 2007 Jun; 27(6):813-24.
Score: 0.017